1 drug(s) with this reaction
373 total reports
Platelet Count Increased has been reported as an adverse reaction across 1 drug(s) manufactured by Amgen Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 373 adverse event reports mention platelet count increased in connection with Amgen Inc products.
This page provides a breakdown of which Amgen Inc drugs are most commonly associated with platelet count increased, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Amgen Inc drugs have platelet count increased listed in their FDA adverse event reports, sorted by report count:
In addition to platelet count increased, the following adverse reactions have been reported across Amgen Inc's drug portfolio:
1 drug(s) manufactured by Amgen Inc have platelet count increased listed in their FDA adverse event reports: ROMIPLOSTIM.
There are a combined 373 reports of platelet count increased across 1 Amgen Inc drug(s) in the FDA adverse event database.